Pace Life Sciences provides comprehensive contract research and manufacturing solutions to accelerate the development and commercialization of pharmaceutical and biopharmaceutical products through their U.S.-owned and operated CRO/CDMO network of facilities. The company supports clients from preclinical development and support through to commercial manufacturing, with capabilities that include small molecule, biologics, nucleic acid, and novel molecules.